Merck’s Oral PCSK9 Inhibitor Shows Promise in Phas...
Category : Clinical Trial Update 3 September 2025Merck (MSD outside the US and Canada) reported positive topline results from its phase 3 CORALreef L...
Clinical Trial Update
Oculis to Showcase Late-Stage Pipeline at Major Re...
Category : Clinical Trial Update 3 September 2025Oculis Holding AG, a biopharma company advancing treatments for ophthalmic and neuro-ophthalmic dise...
Baxdrostat Phase III Trial Delivers Breakthrough i...
Category : Clinical Trial Update 3 September 2025Baxdrostat has achieved positive full results in the BaxHTN Phase III trial, showing a statistically...
AMI Pharm’s AYP-101 Shows Strong Phase 2 Results f...
Category : Clinical Trial Update 2 September 2025AMI Pharm’s novel injectable, AYP-101, has delivered promising Phase 2 results in treating sub...
Oslo University Hospital Launches Phase 2 Trial of...
Category : Clinical Trial Update 2 September 2025Oslo University Hospital will initiate a multicentre randomized Phase 2 trial of ILB® in Amyotro...
Latest Newsletter Post
-
Baxdrostat Phase III Trial Delivers..
3 September 2025
-
Oculis to Showcase Late-Stage Pipel..
3 September 2025
-
Merck’s Oral PCSK9 Inhibitor Shows..
3 September 2025
-
Oslo University Hospital Launches P..
2 September 2025
-
AMI Pharm’s AYP-101 Shows Strong Ph..
2 September 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com